Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Caballero

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantationJ M Calvo-Villas, A Martín, E Conde, et al.
Nature|May 30, 2009
Broad line emission from iron K- and L-shell transitions in the active galaxy 1H 0707-495A C Fabian, A Zoghbi, R R Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
Nature|December 8, 2022
A nearby long gamma-ray burst from a merger of compact objectsE Troja, C L Fryer, B O'Connor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupM D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
Nature|December 23, 2021
Very-high-frequency oscillations in the main peak of a magnetar giant flareA J Castro-Tirado, N Østgaard, E Göǧüş, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantationJ M Calvo-Villas, A Martín, E Conde, et al.
Nature|May 30, 2009
Broad line emission from iron K- and L-shell transitions in the active galaxy 1H 0707-495A C Fabian, A Zoghbi, R R Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
Nature|December 8, 2022
A nearby long gamma-ray burst from a merger of compact objectsE Troja, C L Fryer, B O'Connor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupM D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
Nature|December 23, 2021
Very-high-frequency oscillations in the main peak of a magnetar giant flareA J Castro-Tirado, N Østgaard, E Göǧüş, et al.
Pageof 8